You are on Trendlyne India. Click here to go to United States website or make India as your default
  1. Stocks
  2. Vivanza Biosciences Ltd.
  3. Swot
swot-logo

Vivanza Biosciences Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Vivanza Biosciences Ltd. has 6 Strengths, 18 Weaknesses, 0 Opportunities and 2 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

PEG lower than Industry PEG

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Growth in Net Profit with increasing Profit Margin (QoQ)

Company with Zero Promoter Pledge

Stock with Low PE (PE < = 10)

Volume Shockers

Promoter decreasing their shareholding

Promoter holding decreased by more than -2% QoQ

Negative profit growth, promoters decreasing shareholding QoQ

New 52 week low today

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Degrowth in Revenue and Profit

Declining Net Cash Flow : Companies not able to generate net cash

Major fall in TTM Net Profit

Fall in Quarterly Revenue and Net Profit (YoY)

Weak performer : Stock lost more than 20% in 1 month

Weak Momentum: Price below Short, Medium and Long Term Averages

Companies Increasing Debt as per Annual Report

Increasing Trend in Non-Core Income

High volume, top losers

Highest fall from 52 Week High

Top Losers

Stocks Underperforming their Industry Price Change in the Quarter

Big Deal (Insider and SAST) sells last month greater than 1% of total shares

Insiders sold stocks

High Piotroski Score - Companies with strong financials

Significant Change in Promoter Shareholding - Latest Quarter

Decline in Quarterly Net Profit with falling Profit Margin (YoY)

New 52 Week Low